ACB · Aurora Cannabis Inc.

Aurora Cannabis Inc. has executed a strategic acquisition through its wholly owned subsidiary, Aurora Sub, which indirectly purchased 100% of Safari Flower Company (9869247 Canada Limited) for aggregate consideration valued at $26.5 million. This transaction represents a significant expansion of Aurora's operational capabilities in the regulated cannabis market, specifically targeting EU GMP certification which is critical for international medical cannabis distribution. The consideration structure includes both equity and cash components, with Aurora issuing 2,417,180 common shares and paying $15 million in cash at closing, plus an additional $2 million contingent payment. The acquisition of an established EU GMP certified cultivator and manufacturer provides Aurora with immediate operational infrastructure and regulatory compliance in key markets, potentially accelerating international growth opportunities. The transaction's material change date of April 14, 2026, followed by prompt public disclosure through a press release on April 15, 2026, demonstrates the company's commitment to transparent communication with investors regarding strategic moves that could impact future revenue streams and market positioning.